Health News Review

This Boston Globe blog post gave its audience a more thorough understanding of an emerging approach to virtual colonoscopy than the Wall Street Journal.

Our Review Summary

Look at the way the Boston Globe approached this story compared to the Wall Street Journal. The difference is subtle but important. The Journal focused too narrowly on the idea that patients might be able to avoid cleansing their colons before going in to get a computer scan of their intestines. The Globe, under the same deadline pressure, placed the new research into the larger context of the growing but complicated array of methods to detect colon cancer and precancerous polyps early.


Why This Matters

The Globe rightly points out that colonscopy is not the only option for people hoping to catch cancer early. This is crucial for readers to have a clear understanding of screening and prevention options. The Wall Street Journal got the news out first, but the Globe provided readers better information.


Criteria

Satisfactory

Does the story adequately discuss the costs of the intervention?

Satisfactory

The story mentioned costs and insurance coverage, while the Wall Street Journal story on the same topic mentioned neither. The Globe wrote, “Medicare doesn’t provide coverage for the imaging test, which Zalis said costs about one-third as much as the traditional scope screening.”

Satisfactory

Does the story adequately quantify the benefits of the treatment/test/product/procedure?

Satisfactory

The lead of the story says, “A new method of performing virtual colonoscopy using a CT scan — which doesn’t involve the dreaded laxative preparation to clear the colon the night before — may be about as effective as a standard colonoscopy at identifying the large polyps most likely to become cancerous, according to research conducted at Massachusetts General Hospital, Brigham and Women’s Hospital, and elsewhere.” Later, it amplifies this claim by providing the numbers from the study: “In the study of 605 patients, published Monday in the Annals of Internal Medicine, the prep-free virtual colonoscopy was able to identify more than 90 percent of suspicious polyps that were 10 millimeters or larger, compared with 95 percent identified when the same patients later had a standard colonoscopy.” It also provided some data to back up the statement found in the story that, “Surveys suggest that patients find the prep — required for both colonoscopy and traditional virtual colonoscopy — to be the worst part of screening.” The story said, “Of the study participants who expressed a preference, 62 percent said they preferred the prep-free CT procedure over the colonoscopy.”

Satisfactory

Does the story adequately explain/quantify the harms of the intervention?

Satisfactory

What this story did that a Wall Street Journal story on the same topic failed to do as thoroughly was explain the potential harms – both from virtual colonoscopy and the traditional methods. It said, “Virtual colonoscopy, with or without prep, has some limitations. About one in five patients must undergo a standard colonoscopy after the imaging procedure to have suspicious looking polyps snipped off and biopsied. The CT scan also delivers a dose of radiation that — while only one-fifth of the dose of an abdominal CT scan — was significant enough to raise the flags of the US Preventive Services Task Force. The government advisory group decided in 2008 not to recommend the use of virtual colonoscopy, saying that evidence wasn’t sufficient enough to prove that the test’s benefits outweighed its harms, which include a dose of radiation with every screening test. (Standard colonoscopy also has rare complications such as an adverse reaction to the sedative, perforation to the colon, and bleeding from the site where the polyp was taken.)” We rarely see this level of detail in a piece, and it shows what a reporter who has command of the topic can do in a relatively small amount of space.

Not Satisfactory

Does the story seem to grasp the quality of the evidence?

Not Satisfactory

The Globe did a nice job explaining the mechanics of the study. But it didn’t include any discussion of the limitations of the research, as MedPage Today reported:

The researchers cautioned that they had only three people reading all the images in the study and there were variations in their performance.

Other limitations were the size of the study and the quality of the survey data.

“Restricting study to a low-risk cohort limited the prevalence of lesions and the study’s statistical power, especially for polyps 10 mm or larger,” they added.

Satisfactory

Does the story commit disease-mongering?

Satisfactory

The story did not engage in disease mongering. Instead, it pointed out both the number of Americans who are not properly screened and the range of available options for screening, saying, “Only one in six Americans over age 50 get the American Cancer Society’s recommended screening for colon cancer: a colonoscopy every 10 years, or a flexible sigmoidoscopy, virtual colonoscopy, or barium enema imaging every five years.”

Satisfactory

Does the story use independent sources and identify conflicts of interest?

Satisfactory

The story quoted  Dr. Durado Brooks, director of prostate and colon cancer for the American Cancer Society. It also noted high in the story that the research “was partially funded by GE Healthcare, manufacturer of the CT imaging device.” It would have been worth noting — as the Wall Street Journal did – that the author quoted in the piece also developed the software involved, which could make the success of this type of screening profitable for him.

Satisfactory

Does the story compare the new approach with existing alternatives?

Satisfactory

First and foremost, the story mentions alternatives to colonoscopy, while other coverage of the same study failed to mention alternatives. It also explains why US Preventive Services Task Force has decided against recommending virtual colonoscopy. The Wall Street Journal, by comparison, wrote that the advent of virtual colonoscopy had eliminated the need for traditional scoping. The Globe also says, “Traditional colonscopy also trumps the virtual test when is comes to detecting smaller polyps, less than 10 millimeters in size. The new study found that virtual colonosopy detected only 70 percent of polyps under 8 millimeters in size, compared with 88 percent detected by a scope. What’s not clear, though, is whether missing these smaller polyps will make a difference in terms of catching growths before they turn into cancer.”

Satisfactory

Does the story establish the availability of the treatment/test/product/procedure?

Satisfactory

The story makes it clear that this is a technique that is in the testing phase, saying, “If the finding is confirmed by larger studies, the technique could eventually serve as a first-line screening tool for colon cancer, especially for the many people who avoid screening altogether.”

Satisfactory

Does the story establish the true novelty of the approach?

Satisfactory

The relative novelty of the approach -  using a contrast agent which can then be digitally erased from the scan using a computer software program – was clear in the story.

Satisfactory

Does the story appear to rely solely or largely on a news release?

Satisfactory

The story does not rely on a press release.

Total Score: 9 of 10 Satisfactory


We Welcome Comments

But please note: We will delete comments that include personal attacks, unfounded allegations, unverified facts, product pitches, profanity or any from anyone who doesn't list what appears to be an actual email address. We will also end any thread of repetitive comments. We don't give medical advice so we won't respond to questions asking for it. Please see more on our comments policy.